# Tempest Therapeutics, Inc.: Form 8-K, filed Jan 10, 2017

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2017-01-10
- Accepted by EDGAR: Jan 9, 2017, 21:50 ET
- Period: 2017-01-05
- Accession: 0001104659-17-001600
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000110465917001600/a17-1665_28k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000110465917001600/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000110465917001600/a17-1665_28k.htm

Filed Jan 10, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-001600. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
